Filing Details

Accession Number:
0001367644-20-000023
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-03-02 17:28:48
Reporting Period:
2020-02-27
Accepted Time:
2020-03-02 17:28:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403769 Sue Bailey 400 Professional Dr, Suite 400
Gaithersburg MD 20879
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-02-27 6,572 $56.93 39,761 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Consists of restricted stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan, as amended.
  2. The price reported is the weighted average sale price. These shares were sold in multiple transactions in prices ranging from $56.50 to $57.49.